Oncogenex Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Oncogenex Pharmaceuticals Inc
TickerACHV
CIK #0000949858
CUSIP004468104
SectorLife Sciences - In Vitro & In Vivo Diagnostic Substances
Address1522 217th Place SE, Bothell, WA 98021
Source [EDGAR]
CIK Filing 2011 - 2025
[0000949858] 10-K
[0000949858] 10-Q
[0000949858] 3
[0000949858] 4
[0000949858] 5
[0000949858] 8-K
[0000949858] D
[0000949858] SC 13D
[0000949858] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Alyeska Investment Group LP Achieve Life Sciences Inc [2025-08-14] 0.0
Vanguard Group Inc Achieve Life Sciences Inc [2024-11-04] 5.65
BlackRock Inc Achieve Life Sciences Inc [2024-10-25] 6.0
Propel Bio Management LLC Achieve Life Sciences Inc [2024-05-17] 6.81
Franklin Resources Inc Achieve Life Sciences Inc [2024-03-11] 12.0
Callahan Patrick J III Achieve Life Sciences Inc [2024-02-27] 0.9
Dialectic Capital Management LP Achieve Life Sciences Inc [2023-04-18] 19.68
Dialectic Capital Management LP Achieve Life Sciences Inc [2023-01-20] 19.5
Contrarian Achieve SPV LP Achieve Life Sciences Inc [2022-11-28] 7.369
Dialectic Capital Management LP Achieve Life Sciences Inc [2022-11-21] 19.5
SVB Financial Group Achieve Life Sciences Inc [2021-12-29] 14.5
Francis Capital Management LLC Achieve Life Sciences Inc [2021-01-07] 5.0
Packer Paul Achieve Life Sciences Inc [2020-12-04] 5.8
Pura Vida Investments LLC Achieve Life Sciences Inc [2019-12-27] 7.79
CVI Investments Inc Achieve Life Sciences Inc [2019-12-26] 0.9
Adamas Health Care Fund Achieve Life Sciences Inc [2019-05-28] 5.37
UBS Group AG Achieve Life Sciences Inc [2019-02-14] 6.74
SIO Capital Management LLC Achieve Life Sciences Inc [2019-02-14] 8.89
Armistice Capital LLC Achieve Life Sciences Inc [2018-10-11] 7.6
Hirschman Orin Achieve Life Sciences Inc [2018-07-03] 7.3
Sabby Management LLC Achieve Life Sciences Inc [2018-06-19] 6.49
Schacter Robert Achieve Life Sciences Inc [2017-08-11] 0.0
Stewart Richard Alistair Achieve Life Sciences Inc [2017-08-11] 19.4
Clarke Anthony Achieve Life Sciences Inc [2017-08-11] 6.6
Martell Ron Achieve Life Sciences Inc [2017-08-11] 0.0
Biotechnology Value Fund L P Oncogenex Pharmaceuticals Inc [2014-12-12] 2.98
Sabby Management LLC Oncogenex Pharmaceuticals Inc [2014-11-07] 4.15
Great Point Partners LLC Oncogenex Pharmaceuticals Inc [2014-07-07] 0.99
FMR LLC Oncogenex Pharmaceuticals Inc [2012-04-10] 0.0
Tang Capital Partners LP Oncogenex Pharmaceuticals Inc [2012-03-22] 5.8
BlackRock Inc Oncogenex Pharmaceuticals Inc [2012-02-09] 5.78
Form 3/4/5 Filer 2011 - 2025
Phelan Nancy R.
Achieve Life Sciences Inc
Slaoui Kristen B.
Sellig Thomas
Martell Bridget A
King Thomas Braxton
Duty Stuart
Oki Mark K
Stewart Richard Alistair
Wan Jerry
Xinos Jaime
Jacobs Cindy
Bencich John
Himes Vaughn B
SVB Innovation Credit Partners VIII, LLC
SVB Innovation Credit Partners VIII-A, LLC
SVB Innovation Credit Fund VIII, L.P.
SVB Financial Group
Innovation Credit Fund VIII-A, L.P.
Dialectic Capital Management LP
Dialectic Partners, LLC
Fichthorn John
Dialectic LS Manager LLC
Dialectic Life Sciences SPV LLC
Moyes Jay M
Joseph Donald
Mattingly Martin A
Clarke Anthony
Parker H Stewart
Cormack Scott Daniel
Armistice Capital Master Fund Ltd.
Boyd Steven
Armistice Capital LLC
Schacter Robert
Goldstein Jack
Smith David V
Clendeninn Neil James
Wyrick Susan D.
Griffin Michelle Renee
Lawrence Cameron William
Form 13F Holdings
Firm Period DFND Voting Shares
Propel Bio Management LLC [2025-06-30] DFND 3,601,913 6,153,091
Franklin Resources Inc [2025-06-30] DFND 4,459,014 4,459,014
Alyeska Investment Group LP [2025-06-30] SOLE 3,504,333 3,504,333
Vanguard Group Inc [2025-06-30] SOLE 0 2,135,069
Clearline Capital LP [2025-06-30] SOLE 1,326,259 1,326,259
Simplify Asset Management Inc [2025-06-30] SOLE 1,184,512 1,184,512
Hudson Bay Capital Management LP [2025-06-30] SOLE 1,173,532 1,173,532
Heights Capital Management Inc [2025-06-30] OTR 989,509 989,509
Nantahala Capital Management LLC [2025-06-30] SOLE 898,885 898,885
Millennium Management LLC [2025-06-30] SOLE 386,200 386,200
Geode Capital Management LLC [2025-06-30] DFND 362,200 362,200
Stonepine Capital Management LLC [2025-06-30] SOLE 333,333 333,333
BlackRock, Inc. [2025-06-30] SOLE 314,699 314,699
Raymond James Financial Inc [2025-06-30] DFND 0 295,058
Shay Capital LLC [2025-06-30] SOLE 292,647 292,647
LPL Financial LLC [2025-06-30] SOLE 0 255,833
Long Focus Capital Management LLC [2025-06-30] SOLE 248,099 248,099
Northern Trust Corp [2025-06-30] DFND 215,845 215,845
Caption Management LLC [2025-06-30] SOLE 200,000 200,000
State Street Corp [2025-06-30] DFND 157,884 157,884
Highbridge Capital Management LLC [2025-06-30] SOLE 0 132,937
Royal Bank of Canada [2025-06-30] DFND 117,934 117,934
Y-Intercept (Hong Kong) Ltd [2025-06-30] SOLE 116,409 116,409
Morgan Stanley [2025-06-30] DFND 103,384 106,297
Qube Research & Technologies Ltd [2025-06-30] SOLE 102,581 102,581
Alpine Global Management, LLC [2025-06-30] SOLE 100,000 100,000
UBS Group AG [2025-06-30] DFND 84,914 84,914
Susquehanna International Group LLP [2025-06-30] OTR 72,715 83,315
Jane Street Group LLC [2025-06-30] DFND 70,452 70,452
Brevan Howard Capital Management LP [2025-06-30] DFND 64,348 64,348
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com